1 / 7

Part 5 Final

Part 5 Final. Laboratory Work-Up. Algorithm for patients with jaundice. Tumor Markers. CA 19-9. 297 U/mL. Patients with pancreatic carcinoma, 75-85% have elevated CA 19-9 levels . CA 19-9 value of greater than 100 U/mL is highly specific for malignancy, usually pancreatic. CEA.

lilike
Download Presentation

Part 5 Final

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Part 5 Final

  2. Laboratory Work-Up

  3. Algorithm for patients with jaundice

  4. Tumor Markers

  5. CA 19-9 297 U/mL • Patients with pancreatic carcinoma, 75-85% have elevated CA 19-9 levels. CA 19-9 value of greater than 100 U/mL is highly specific for malignancy, usually pancreatic. CEA • The reference range is less than or equal to 2.5 mg/mL. • Only 40-45% of patients with pancreatic carcinoma have elevated CEA levels.

More Related